PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
11-Sep-2024 Ground-breaking study will use AI to explore links between chronic inflammation, diet and long-term health conditions University of East Anglia (UEA)
11-Sep-2024 Strategic collaboration with Valeos to accelerate production and supply of high-THC medical cannabis Celadon Pharmaceuticals Plc
11-Sep-2024 Pharmacosmos strengthens its cryopreservation formulations portfolio with PentaHibe® Complete Pharmacosmos
11-Sep-2024 AstraZeneca announces the completion of the clinical programme to support the transition of Breztri to next-generation propellant with near-zero Global Warming Potential AstraZeneca
11-Sep-2024 BIOCAPTIVA secures US patent for DNA-extraction technology to enhance cancer management BIOCAPTIVA
11-Sep-2024 Charity launches first-of-its-kind tool to check potential inherited risk of pancreatic cancer Pancreatic Cancer UK
11-Sep-2024 Experimenting with different vapes could be crucial to help people quit smoking University of East Anglia (UEA)
11-Sep-2024 Best Clinical Research Courses in Pune by Fusion Technology Solutions Fusion technology solutions
10-Sep-2024 PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth PharmaForceIQ
09-Sep-2024 Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation Pierre Fabre Laboratories
09-Sep-2024 AstraZeneca announces the completion of the clinical programme to support the transition of Breztri to next-generation propellant with near-zero Global Warming Potential AstraZeneca
09-Sep-2024 TILT Biotherapeutics Presents Clinical Data on TILT-123 After Fully Intravenous Delivery Regimen at ESMO 2024 TILT Biotherapeutics
09-Sep-2024 Anocca Presents Data at ESMO Congress on Preclinical Development of its TCR-T Cell Therapies for Cancer Anocca
09-Sep-2024 Transgene and BioInvent to Present Promising Initial Phase I/IIa Data on Oncolytic Virus, BT-001, at ESMO 2024 Transgene and BioInvent
09-Sep-2024 Sale of Gentronix to Danish group provides an exit for investor Mercia Ventures Mercia Ventures
06-Sep-2024 Xinnate presents TCP-25 data at international dermatology congress Xinnate AB
06-Sep-2024 PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies PureTech Health plc
06-Sep-2024 Asgard Therapeutics’ study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108 Asgard Therapeutics
06-Sep-2024 Realheart to Present Positive Results From Two Preclinical Studies Evaluating Treatment Safety of Its Total Artificial Heart at ISMCS 2024 Scandinavian Real Heart AB
06-Sep-2024 ENA Respiratory Announces Extension of U.S. Department of Defense Funding for Novel Prophylactic Antiviral ENA Respiratory